Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Alvarez ML
Tenofovir DF is associated with decreased HIV-related healthcare costs in HIV-1-infected heavily pre-treated patients with nucleoside reverse transcriptase inhibitors-related toxicity
10th European AIDS Conference / EACS. Dublin, Ireland. 17-20 nov 2005
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Sánchez de la Rosa R
Cost of the NRTI-related toxicities in HIV-1-infected heavily experienced patients
7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Dublin, Ireland. 13-16 nov 2005
Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R
Cost-effectiveness of peginterferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-HCV co-infected patients
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) and awarded a Presidential Poster of Distinction. San Francisco, California, EEUU. 11-15 nov 2005
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). San Francisco, California, EEUU. 11-15 nov 2005
Casado MA
The pharmacoeconomics of anti-HBV treatments. Monothematic conference: From viral pathobiology to the treatment of hepatitis B virus infection
Istanbul, Turkey. 6-8 oct 2005
Casado MA, Garriga R, Pla R
Análisis del impacto presupuestario del tratamiento de la artritis reumatoide con agentes antagonistas del factor de necrosis tumoral
50 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Oviedo, España. 27-30 sep 2005
Casado MA, Ventura JM
Impacto en el presupuesto hospitalario de los interferones pegilados en el tratamiento de los pacientes con hepatitis crónica C
50 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Oviedo, España. 27-30 sep 2005
Casado MA, Álvarez L, Alberdi A
Cómo utilizar los análisis de impacto presupuestario para la toma de decisiones en la selección de medicamentos. El tratamiento de la hepatitis crónica C con interferones pegilados
50 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria (SEFH). Oviedo, España. 27-30 sep 2005
Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R